Federal SB977 prohibits taxpayer-funded gender transition procedures.

Federal SB977, the End Taxpayer Funding of Gender Experimentation Act of 2025, prohibits federal funds from being used for gender transition procedures. This includes hormonal or surgical interventions for gender transition, such as puberty blockers, testosterone, estrogen, and various surgeries. The bill also prevents federal funds from being used for health benefits coverage that includes gender transition procedures. However, it allows non-federal health insurance issuers to offer separate coverage or plans for these procedures, provided they are not paid for with federal funds or credits.

Federal SB977 prohibits taxpayer-funded gender transition procedures.

Federal SB977, the End Taxpayer Funding of Gender Experimentation Act of 2025, prohibits federal funds from being used for gender transition procedures. This includes hormonal or surgical interventions for gender transition, such as puberty blockers, testosterone, estrogen, and various surgeries. The bill also prevents federal funds from being used for health benefits coverage that includes gender transition procedures. However, it allows non-federal health insurance issuers to offer separate coverage or plans for these procedures, provided they are not paid for with federal funds or credits.